Home

sestava neplechu Zdatnost anti influenza a Rozluštit sloužit panel

The seafood Musculus senhousei shows anti-influenza A virus activity by targeting virion envelope lipids - ScienceDirect
The seafood Musculus senhousei shows anti-influenza A virus activity by targeting virion envelope lipids - ScienceDirect

Anti Influenza A Matrix Protein Antibody, clone GA2B | Bio-Rad
Anti Influenza A Matrix Protein Antibody, clone GA2B | Bio-Rad

Mouse anti-Influenza B Virus NP antibody (HRP) (ABIN5707182)
Mouse anti-Influenza B Virus NP antibody (HRP) (ABIN5707182)

Prevention and Treatment of Influenza Using Antiviral Drugs Based on Cost-Effectiveness
Prevention and Treatment of Influenza Using Antiviral Drugs Based on Cost-Effectiveness

InVivoMAb anti-Influenza A virus NP | Bio X Cell
InVivoMAb anti-Influenza A virus NP | Bio X Cell

Influenza A H1N1 A/Brisbane/59/2007, Neuraminidase Antibodies - Kerafast
Influenza A H1N1 A/Brisbane/59/2007, Neuraminidase Antibodies - Kerafast

US Releases Stockpiled Tamiflu Supplies Amid Cold, Flu Treatment Shortages - Bloomberg
US Releases Stockpiled Tamiflu Supplies Amid Cold, Flu Treatment Shortages - Bloomberg

Anti-influenza agents
Anti-influenza agents

A panel of anti-influenza virus nucleoprotein antibodies selected from phage-displayed synthetic antibody libraries with rapid diagnostic capability to distinguish diverse influenza virus subtypes | Scientific Reports
A panel of anti-influenza virus nucleoprotein antibodies selected from phage-displayed synthetic antibody libraries with rapid diagnostic capability to distinguish diverse influenza virus subtypes | Scientific Reports

Currently available anti-influenza drugs | Download Table
Currently available anti-influenza drugs | Download Table

Anti-Influenza A Virus antibody (ab20841) | Abcam
Anti-Influenza A Virus antibody (ab20841) | Abcam

New anti-influenza drugs developed in UK - Thailand Medical News
New anti-influenza drugs developed in UK - Thailand Medical News

Anti-Influenza Treatment: Drugs Currently Used and Under Development | Archivos de Bronconeumología
Anti-Influenza Treatment: Drugs Currently Used and Under Development | Archivos de Bronconeumología

Vaccines | Free Full-Text | Neutralizing Anti-Hemagglutinin Monoclonal Antibodies Induced by Gene-Based Transfer Have Prophylactic and Therapeutic Effects on Influenza Virus Infection
Vaccines | Free Full-Text | Neutralizing Anti-Hemagglutinin Monoclonal Antibodies Induced by Gene-Based Transfer Have Prophylactic and Therapeutic Effects on Influenza Virus Infection

Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial - The Lancet Respiratory Medicine
Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial - The Lancet Respiratory Medicine

Influenza detection and typing: Human influenza virus antibodies
Influenza detection and typing: Human influenza virus antibodies

anti-Influenza A Virus NP monoclonal antibody (C43) – AS ONE INTERNATIONAL
anti-Influenza A Virus NP monoclonal antibody (C43) – AS ONE INTERNATIONAL

list_all_antivirals [TUSOM | Pharmwiki]
list_all_antivirals [TUSOM | Pharmwiki]

Influenza A virus - Wikipedia
Influenza A virus - Wikipedia

Anti-Influenza A Virus Nucleoprotein Antibody [C43] (A335)
Anti-Influenza A Virus Nucleoprotein Antibody [C43] (A335)

Anti-Influenza A virus M1 (matrix protein) antibody (GTX125928) | GeneTex
Anti-Influenza A virus M1 (matrix protein) antibody (GTX125928) | GeneTex

HRP Anti-Influenza A, Matrix Protein, FluAc | SouthernBiotech
HRP Anti-Influenza A, Matrix Protein, FluAc | SouthernBiotech

Development of effective anti-influenza drugs: congeners and conjugates – a review | Journal of Biomedical Science | Full Text
Development of effective anti-influenza drugs: congeners and conjugates – a review | Journal of Biomedical Science | Full Text

Design, Synthesis and Anti-influenza A Virus Evaluation of Oleanolic Acid C3-Glycoconjugates
Design, Synthesis and Anti-influenza A Virus Evaluation of Oleanolic Acid C3-Glycoconjugates

Treatment of Influenza: Prospects of Post-transcriptional Gene Silencing Through Synthetic siRNAs
Treatment of Influenza: Prospects of Post-transcriptional Gene Silencing Through Synthetic siRNAs